Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority study

Introduction Some patients with cervical dystonia (CD) receiving long-term botulinum neurotoxin (BoNT) therapy report early waning of treatment benefit before the typical 12-week reinjection interval. METHODS: This phase 4, open-label, randomized, noninferiority study (CD Flex; NCT01486264) compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Comella, Cynthia, Hauser, Robert A., Isaacson, Stuart H., Truong, Daniel, Oguh, Odinachi, Hui, Jennifer, Molho, Eric S., Brodsky, Matthew, Furr-Stimming, Erin, Comes, Georg, Hast, Michael A., Charles, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938329/
https://www.ncbi.nlm.nih.gov/pubmed/35330880
http://dx.doi.org/10.1016/j.prdoa.2022.100142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938329/
https://www.ncbi.nlm.nih.gov/pubmed/35330880
http://dx.doi.org/10.1016/j.prdoa.2022.100142

Ejemplares similares